[HTML][HTML] Biosimilars in dermatology: The wind of change

MM Constantin, CM Cristea… - Experimental and …, 2019 - spandidos-publications.com
Biosimilars are new drugs, highly similar copies of biological medicines, equally effective
and safe but at lower prices. The aim of this brief review is to provide the current status of …

Clinical pharmacology: Current innovations and future challenges

JL Cracowski, JS Hulot, S Laporte… - Fundamental & …, 2022 - Wiley Online Library
Clinical pharmacology is the study of drugs in humans, from first‐in‐human studies to
randomized controlled trials (RCTs) and benefit–risk ratio assessment in large populations …

[PDF][PDF] Adding innovation diffusion theory to technology acceptance model: Understanding Consumers' intention to use biofuels in Viet Nam

TCT Tran, MS Cheng - International review of management and …, 2017 - researchgate.net
Biofuels are drawing increasing attention on worldwide as substitutes for fossil fuels to help
address energy cost, energy security and global warming. Vietnam is an agricultural country …

[HTML][HTML] Social non-profit bioentrepreneurship: current status and future impact on global health

AH Sadeghi, C Koldeweij… - Frontiers in Public …, 2021 - frontiersin.org
For-profit biotechnological and pharmaceutical companies have played an essential role in
the research and development (R&D) of innovative medical products and drugs for many …

[图书][B] Academic entrepreneurship: How to bring your scientific discovery to a successful commercial product

M Marcolongo - 2017 - books.google.com
The pathway to bringing laboratory discoveries to market is poorly understood and generally
new to many academics. This book serves as an easy-to-read roadmap for translating …

[PDF][PDF] Proposal for an innovating business model for supporting biotechnology companies, ecosystem and their founders

F Heitzmann - Journal of Commercial Biotechnology, 2018 - thinkbiotech.com
The pharmaceutical industry has been revolutionized by the new biotechnology companies
during the last years. Facing patent expirations, lack of innovation and depleting product …

The Complexity of Pharmaceutical Prices: An Economic Analysis

EA Blackstone, JP Fuhr Jr - Journal of Commercial …, 2019 - search.proquest.com
This article examines the complexity of pharmaceutical pricing. Specifically, list prices are
often considerably higher than net prices. PBMs have considerable market power to obtain …

The opportunities to develop a successful entrepreneurship and business model in biotechnology: an overview

P Tyagi, RS Sengar, A Kumar - Journal of commercial …, 2018 - search.proquest.com
Biotechnology is an incredible technology promising a better future worldwide and proved to
be genera of great outcomes. Since its inception it has been projected to bring fantastic …

Entrepreneurship in healthcare biotechnology

N Wakchaure, R Chawla, JS Arora - Biotechnology in Healthcare, 2022 - Elsevier
Entrepreneurship is not a standard characteristic of everyone's personality and requires an
X-factor, which makes them different from the others. Apart from essential entrepreneur traits …

Biotechnology lessons for robotics: Adapting new business models to accelerate innovation

A Boni, C Moehle - Journal of Commercial Biotechnology, 2014 - search.proquest.com
The robotics industry is achieving a level of commercial maturity as evidenced by innovative
products brought to market, and by the increasing pace of emerging robotics companies …